Other headlines for [ELN]

• ELN 11/18/2008 02:08pm
  Elan Corp PLC CEO: Sees 20% market share as achievable over time for Tysarbri, expects to complete pipeline transaction by mid 2009 with Oncology or other drugs- Notes could continue cost cutting measures through more...
  
• ELN 11/10/2008 01:18pm
  Elan Corp PLC Signs agreement with Azur Pharma to Develop a Once-Daily Clozapine- Clozapine is currently marketed in immediate release presentations, including Azur's proprietary orally disintegrating tablet more...
  
• JNJ 11/1/2008 06:03pm
  Johnson & Johnson Inc Study suggests treatment with Paliperidone ER improves symptoms of schizoaffective disorder-Patients with schizoaffective disorder receiving paliperidone extended release tablets (paliperidone ER) more...
  
• BIIB 10/29/2008 04:29pm
  Biogen Idec, Inc. Notified of case of PML in one MS patient taking Tsyabri - filing- the patient had gotten 14 doses of Tysabri before being diagnosed with the brain illness PML
  
• ELN 10/24/2008 09:58am
  Elan Corp PLC Caris & Company Raised ELN to Average from Sell (timing uncertain)- likely pre-open
  

Healthcare sector headlines

• NCST Today 09:48am
  Nucryst Pharmaceuticals Corp Majority holder calls for special meeting of shareholders to consider a return of capital of $0.80/shr
  
• GNBT Today 09:30am
  Generex Biotechnology Announces Positive Results of Metformin Chewing Gum Trial- Results of this fully compliant ICH-GCP conducted study indicate that the MetControl Metformin chewing gum and traditional Metformin tablets more...
  
• Today 09:30am
  Fed sets overnight reverse repos, accepts $25B
  
• 4568.JP Today 09:28am
  Daiichi Sankyo Co Three Studies of Oral Factor Xa Inhibitor DU-176b Accepted for the 50th Annual Meeting of the American Society of Hematology- Results from three studies of its investigational molecule, DU-176b, will more...
  
• GENZ Today 09:22am
  Genzyme Corp European Patent on cross-linked Gel Slurries has been revoked by EPO board of appeal- Announces that the opposition they filed against European Patent EP 0466300 B1 to Genzyme Corporation has been more...